FDA approves new formulation of Hyrimoz adalimumab biosimilarMarch 27, 2023PediatricsGastroenterologyDermatologyRheumatology
Anifrolumab shows promise in refractory discoid lupus erythematosusMarch 27, 2023DermatologyRheumatology
Pilot study evaluates sensitive skin burden in persons of colorMarch 23, 2023Diversity in MedicineDermatology
Expert shares her tips for diagnosing, treating onychomycosisMarch 23, 2023Infectious DiseasesDermatology
Cases of potentially deadly fungus jump 200%: CDCMarch 22, 2023Mixed TopicsInfectious DiseasesDermatology
Phase 3 prurigo nodularis trial shows positive results for nemolizumabMarch 22, 2023DermatologyRare Diseases
Novel therapy shows promise for treating skin-predominant dermatomyositisMarch 21, 2023DermatologyRheumatology
CSU in children: Study identifies biomarkers associated with responses to different treatmentsMarch 19, 2023DermatologyPediatrics
JAK inhibitor safety warnings drawn from rheumatologic data may be misleading in dermatologyMarch 19, 2023DermatologyRheumatology